Home › Funds › Vestal Point Capital, LP › SVRA

Vestal Point Capital, LP position in SVRA

Savara Inc · Health Care

Vestal Point Capital, LP reported holding 2,720,000 shares of SVRA (Savara Inc) in its Q2 2026 13F filing — a position valued at US$16.8M, representing 0.39% of its reported portfolio and ranking #46 among its reported holdings. Vestal Point Capital, LP has disclosed SVRA holdings in 9 of the last 9 reported quarters, going back to Q2 2024.

Latest position (Q2 2026)2.72M sh
Reported value held$16.76M
Portfolio Weight0.39%
First reportedQ2 2024
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Vestal Point Capital, LP's SVRA position evolved

Vestal Point Capital, LP first disclosed a stake in SVRA in Q2 2024 at 6,490,000 shares (US$26.2M). The position peaked in Q3 2024 at 8,090,000 shares, worth US$34.3M. Across 9 filings, Vestal Point Capital, LP increased the stake 5 time(s), trimmed it 2 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 2,720,000 shares valued at US$16.8M — an increase of 119,948 shares quarter over quarter.. Notable position changes include a 64% trim in Q3 2025 (shares rose 69% over the following quarter), a 60% trim in Q4 2025 (shares fell 9% over the following quarter), a 62% increase in Q1 2026 (shares rose 13% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2024 6.49M $26.15M New
Q3 2024 8.09M $34.30M Add
Q4 2024 10.78M $33.08M Add
Q1 2025 11.00M $30.47M Add
Q2 2025 11.02M $25.11M Hold
Q3 2025 4.01M $14.33M Reduce
Q4 2025 1.61M $9.68M Reduce
Q1 2026 2.60M $14.20M Add
Q2 2026 2.72M $16.76M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About SVRA and 13F data

SVRA (Savara Inc) is a Health Care company. 44 other funds we track also report a position in SVRA — the largest reported positions include NEA Management Company, LLC (US$150.7M), Bain Capital Life Sciences Investors, LLC (US$108.4M), Venrock Adviser, LLC (US$90.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding SVRA

All SVRA fund holders →

FAQ

How long has Vestal Point Capital, LP held SVRA?

Vestal Point Capital, LP has disclosed SVRA holdings in 9 of the last 9 reported quarters, going back to Q2 2024.

What is Vestal Point Capital, LP's current position in SVRA?

As of Q2 2026, Vestal Point Capital, LP holds 2.72M shares of SVRA (Savara Inc), valued at $16.76M, representing 0.39% of its reported portfolio and ranking #46.

Has Vestal Point Capital, LP been buying or selling SVRA?

In the latest 13F filing (Q2 2026), Vestal Point Capital, LP increased its position in SVRA. The position peaked in Q3 2024 at 8.09M shares.

Which other funds hold SVRA?

Other major institutional holders of SVRA include NEA Management Company, LLC, Bain Capital Life Sciences Investors, LLC, Venrock Adviser, LLC, among 44 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.